SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Trading Update

21 Apr 2026 07:00

RNS Number : 2022B
Accsys Technologies PLC
21 April 2026
 

AIM: AXS

Euronext Amsterdam: AXS

 

21 April 2026

 

Accsys Technologies PLC

("Accsys", the "Group" or the "Company")

 

Trading Update

 

Record Accoya sales volumes with significant strategic progress

 

Accsys, the world's leading supplier of premium, high performance and sustainable wood building materials, today provides an update on its performance for the year ended 31 March 2026 ("FY26"). All numbers in this announcement are unaudited.

 

Accsys is pleased to announce a strong performance for FY26 and expects full-year results to be in line with market consensus¹, reflecting continued significant progress in delivering on Phase 1 of its FOCUS strategy.

 

Full year performance: 

FY26  

Unaudited 

FY25 

Actual 

Change

Like-for-like

change² 

Revenue 

Group

€153m 

€137m

 +12% 

+20%

Aggregated (Group plus Joint Venture)³ 

€183m 

€147m 

+24%

 

Sales Volumes m³ 

Group 

60,384m3

57,104m3

+6%

+13%

Joint Venture (JV)

16,853m3

6,760m3

+149%

 +60% 

Total (Group plus JV) 

77,237m3

63,864m3

+21%

 

 

· Record total global sales volumes of 77,237m3 demonstrate continued strong demand for Accoya amidst challenging macroeconomic conditions:

Group sales volumes up 13% on a like-for-like basis with robust growth in all markets: 60% North America, 12% UK&I, 23% Rest of Europe and 9% Rest of World

9% growth in Accoya for Tricoya

 

· Group revenues increased by 20% on a like-for-like basis driven by solid trading performance across all regions, continued pricing discipline and favourable sales mix reflecting robust demand for Accoya Color, supported by the H1 production capacity increase at Barry, UK

 

· The Company expects FY26 adjusted EBITDA to be in line with market consensus

 

· Excellent performance in North America:

Significant sales volume growth of 60% in North America following the first full financial year of trading for Accoya USA, demonstrating the sizeable market opportunity. This growth captures the brand strength, pricing power and innovative technology of our products and effective commercial and operational execution

Management has successfully mitigated the impact of tariffs on imported lumber into the USA, introduced in October 2025, and is continuing to monitor the situation

 

· Continued focus on capital allocation towards deleveraging with reduction in leverage ratio and net debt to €41.4m at 31 March 2026 (€42.6m, 31 March 2025)

Dr Jelena Arsic van Os commented:

"I am proud of Accsys' impressive performance in FY26, reflecting disciplined execution of our FOCUS strategy, with record Accoya volumes driving strong revenue growth, continued market share gains and significantly improved profitability. Our differentiated offering is resonating with customers, and the progress of our Accoya USA joint venture reinforces the strength of our strategic positioning in North America.

While remaining mindful of current geopolitical events, we are delivering against our priorities, strengthening the business, enhancing resilience, and building a scalable platform for sustainable long-term growth."

The Group's financial results for the year ended 31 March 2026 will be announced on the 16 June 2026.

Notes:

1) Accsys considers market consensus FY26 Adjusted EBITDA to be €21.0 million as at 31 March 2026.

2) The comparative period, FY25, included 3,802m³ of Group sales to North America. Since the start-up of Accoya USA in September 2024 all North American sales are served by the JV. The like-for-like change in sales volumes and revenues excludes the effect of these sales from the FY25 Group comparators whilst including them within the FY25 JV sales volumes comparator.

3) Accsys has a 60% shareholding in Accoya USA, a joint venture (JV) with Eastman Chemical Company which commenced operations during H1 FY25. Whilst the JV is equity accounted for financial reporting purposes, the aggregated revenue figure includes 60% of the JV revenue.

4) At constant exchange rates, aggregated revenue growth would be +25%

5)Total Sales Volumes include all Group sales and 100% of sales from the JV

6) Adjusted EBITDA being earnings before interest, tax, depreciation, amortisation and exceptional items of Accsys plus 60% of the JV's EBITDA.

 

 

Ends

Enquiries:

Accsys Investor Relations ir@accsysplc.com

 

Panmure Liberum (London) - Nomad and Broker

Nicholas How (NOMAD), Will King +44 (0) 20 3100 2000

 

ABN Amro (Amsterdam) - Broker

Richard van Etten, Dennis van Helmond +31 (0) 20 344 2000

 

Camarco (UK) accsys@camarco.co.uk

Ginny Pulbrook, Tom Huddart, Tilly Butcher +44 (0)20 3757 4980

Huijskens Sassen Communications (NL)

Clemens Sassen, Tessa Nelissen +31 (0) 20 68 55 955

Notes to editors:

 

Accsys (Accsys Technologies PLC) is disrupting the building materials industry with its high-performance wood products and proprietary technology. Driven by its purpose of "changing wood to change the world", Accsys takes fast-growing, certified sustainable wood and turns it into long lasting, eco-friendly building materials - backed by warranties of up to 50 years. Operating in the rapidly growing global wood construction market, Accsys has an established manufacturing footprint in Europe and North America with active product distribution in more than 25 countries. Accsys is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'.

Accsys is a Participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business.

Visit www.accsysplc.com 

 

Accoya® is the global leader for high-performance wood. Created through a proprietary acetylation process developed by Accsys, Accoya delivers superior durability and stability, backed by an industry-leading warranty of up to 50 years. It holds Cradle to Cradle Certified® Gold (Full Scope - V3.1) status for its circular economy benefits. Combining the natural beauty of wood with exceptional performance, Accoya is the preferred choice for windows, doors, cladding, and decking - outperforming hardwoods and manmade materials in durability, stability, and sustainability.

Tricoya® acetylated wood chips redefine panel products, creating next-generation panels that thrive outdoors and in wet environments. Recognised as the biggest leap in wood composites in over 30 years, Tricoya panels combine the strength and versatility of traditional products with unmatched durability and eco-friendliness - backed by a warranty of up to 50 years - expanding design and construction possibilities like never before.

To find out more visit: www.accoya.com

Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. 'Accsys' and 'Accsys Technologies' are trading names of Titan Wood Limited ("TWL"), a wholly-owned subsidiary of Accsys Technologies PLC. Accoya®, Tricoya® and the Trimarque Device are registered trademarks owned by TWL, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered brand trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLDSTIIFIR
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.